Hospital Readmissions Reduction Program
Key result
Hospital Readmissions Reduction Program penalizes hospitals with excess 30-day readmissions for AMI, HF, and pneumonia.
Why the study?
Hospital readmissions are common, costly, and associated with poor outcomes, prompting the implementation of the Hospital Readmission Reduction Program to reduce 30-day readmissions for key conditions.
Population
Medicare beneficiaries hospitalized with acute myocardial infarction, heart failure, or pneumonia
Comparison
Hospitals with higher-than-expected vs lower-than-expected 30-day readmission rates under HRRP
Design
Review of the Hospital Readmission Reduction Program and its impact
Follow-up
30-day readmission period
Authors
Discussion
Loading...
Member takes
Key expert perspectives
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
AKAshish K. JhaGlobal health professor, Harvard T.H. Chan School of Public Health
“Although early data suggested that HRRP was improving care, new evidence suggests that the benefits may have been much smaller than understood and that there might have been meaningful, unintended consequences. One thing is becoming clear: HRRP is not working as well as its architects had hoped, and it is time to take a fresh look at the program.”
JFJose F. FigueroaHealth policy researcher, Harvard T.H. Chan School of Public Health
“More recent evidence, however, suggests that readmission reductions initially credited to the program were overstated, and instead, primarily due to nationwide changes in the coding intensity and statistical artifact, including regression to the mean and secular decreases in index admissions, rather than changes in care delivery.”
NSNeeraj SoodHealth economics professor, USC Schaeffer Center
“We knew that some of the improvements in readmissions at penalized hospitals were due to regression to the mean as readmissions are determined both by care quality and random events such as a patient falls or bad weather. We wanted to know how much of the improved readmissions were due to regression to the mean versus improvements in quality of care. Answering this question is critical for understanding the true effects of Medicare's decision to penalize hospitals for excess readmissions.”
Overview
Policy review reports the impact of financial penalties on hospital readmissions in Medicare beneficiaries, highlighting trade-offs in transitional care and healthcare costs.
Key Points
- Review the origins, penalty structures, and overall clinical and economic impacts of the Hospital Readmissions Reduction Program established under the Affordable Care Act.
- Narrative policy analysis evaluating the implementation of Medicare financial penalties under the Affordable Care Act beginning in 2012.
- Examines institutional performance metrics based on 30-day risk-standardized readmission rates for acute myocardial infarction, heart failure, and pneumonia.
- Historically, approximately 20% of all Medicare discharges experienced a readmission within 30 days, with 12% classified as potentially avoidable.
- Preventing 10% of avoidable readmissions was projected to save the Medicare program approximately $1 billion.
- The implementation of financial penalties under the inpatient prospective payment system spurred major changes in hospital transitional care strategies.
PICO
P
Population
Hospital readmissions
E
Exposure / Comparator
Hospital Readmissions Reduction Program
Cite This Study
McIlvennan et al. (2015) conducted a review in Hospital readmissions. Hospital Readmissions Reduction Program was evaluated. The Hospital Readmissions Reduction Program financially penalizes hospitals with higher-than-expected 30-day readmission rates for acute myocardial infarction, heart failure, and pneumonia.